AcuCort AB (STU:NV5) E10: €0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:NV5 AcuCort AB STU:NV5
31 GF Score
Price €0.00
! 2 Warning Signs
View Full Analysis

What is AcuCort AB E10?

AcuCort AB STU:NV5 31 E10 is €0.00 as of Mar. 2026. GuruFocus rates STU:NV5 with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

Note: As E10 is a main component used to calculate Shiller PE Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation sectione below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AcuCort AB's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.00 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-26), AcuCort AB's current stock price is €0.001. AcuCort AB's E10 for the quarter that ended in Mar. 2026 was €0.00. AcuCort AB's Shiller PE Ratio of today is .


AcuCort AB  (STU:NV5) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


AcuCort AB E10 Related Terms


AcuCort AB E10 Historical Data

* Premium members only.

The historical data trend for AcuCort AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AcuCort AB E10 Chart

AcuCort AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.02

AcuCort AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.03 -0.02 -0.02 0.00

STU:NV5 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, AcuCort AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AcuCort AB Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AcuCort AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AcuCort AB's Shiller PE Ratio falls into.


STU:NV5
31GF Score
AcuCort AB STU:NV5
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AcuCort AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AcuCort AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0/133.5600*133.5600
=0.000

Current CPI (Mar. 2026) = 133.5600.

AcuCort AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.006 101.019 -0.008
201609 -0.004 101.138 -0.005
201612 -0.005 102.022 -0.007
201703 -0.012 102.022 -0.016
201706 -0.012 102.752 -0.016
201709 -0.010 103.279 -0.013
201712 -0.005 103.793 -0.006
201803 -0.012 103.962 -0.015
201806 -0.016 104.875 -0.020
201809 -0.012 105.679 -0.015
201812 -0.008 105.912 -0.010
201903 -0.009 105.886 -0.011
201906 -0.014 106.742 -0.018
201909 -0.016 107.214 -0.020
201912 -0.007 107.766 -0.009
202003 -0.006 106.563 -0.008
202006 -0.007 107.498 -0.009
202009 -0.005 107.635 -0.006
202012 -0.006 108.296 -0.007
202103 -0.007 108.360 -0.009
202106 -0.011 108.928 -0.013
202109 -0.010 110.338 -0.012
202112 -0.006 112.486 -0.007
202203 -0.008 114.825 -0.009
202206 -0.007 118.384 -0.008
202209 -0.007 122.296 -0.008
202212 -0.015 126.365 -0.016
202303 -0.008 127.042 -0.008
202306 -0.007 129.407 -0.007
202309 -0.007 130.224 -0.007
202312 -0.011 131.912 -0.011
202403 -0.004 132.205 -0.004
202406 -0.004 132.716 -0.004
202409 -0.002 132.304 -0.002
202412 -0.007 132.987 -0.007
202503 -0.003 132.825 -0.003
202506 -0.003 133.699 -0.003
202509 -0.002 133.480 -0.002
202512 0.000 133.390 0.000
202603 0.000 133.560 0.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.00 mean?
AcuCort AB (STU:NV5) has a E10 of €0.00 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on AcuCort AB and its competitors.
Is AcuCort AB's E10 too high?
AcuCort AB's current E10 is €0.00. Overall, AcuCort AB has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does AcuCort AB's E10 compare to ZTS and UTHR?
AcuCort AB's E10 of €0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on AcuCort AB and its competitors. AcuCort AB's current E10 is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AcuCort AB stock overvalued right now?
AcuCort AB (STU:NV5) has a current E10 of €0.00. The current E10 is €0.00. AcuCort AB's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For AcuCort AB (STU:NV5), the current E10 is €0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AcuCort AB Business Description

Other Exchanges ACUC:Sweden
Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
AcuCort AB is an innovative biotechnology company that identifies, develops and commercializes smart drugs that meet the patient's needs for a user-friendly and effective treatment.
31GF Score

Get the complete analysis for STU:NV5

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00
Price